Arrowhead Pharmaceuticals stockARWR
Arrowhead Pharmaceuticals trades at $57.46, 39.8% below its 52-week high (Jul 22, 2026). The price is below its 50- and 200-day averages, a downtrend. −13.5% year to date, +42.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 12, 2026.
Ratings, candles, signals and the screener for ARWR — after you log in
Open the terminalFrequently asked questions about Arrowhead Pharmaceuticals
What is the Arrowhead Pharmaceuticals stock price?
At the close on Nov 5, 2026: $57.46 (−6.80% on the day). 52-week high: $95.49 on Jul 22, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Arrowhead Pharmaceuticals report earnings?
The next quarterly report is on Nov 12, 2026. Last quarter, earnings per share changed −8% year over year, revenue +171%.
Does Arrowhead Pharmaceuticals pay dividends?
No, Arrowhead Pharmaceuticals does not pay dividends.
Where does Arrowhead Pharmaceuticals trade and how to buy it?
Ticker ARWR, exchange Nasdaq, listed since 1993. You can buy it through a broker with access to US exchanges.
Should I buy Arrowhead Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ARWR are in the terminal after you log in.